Peripheral artery disease

  • significant risk factor for:

    • cvs events

    • lower limb amputation

  • increased among:

    • elderly

    • smokers

      • four times more likely
    • DM

      • 1/2 of amputations
  • pedal pulse easily felt on examination excludes peripheral artery disease

  • physical exam:

    • reduced/absent pedal pulses

    • skin =

      • cool

      • shiny

      • hairless

      • thin

    • thickening of nails

    • abnormal CRT

    • pallor of distal extremities on elevation

    • leg pain

    • tissue ulceration or necrosis

  • classical symptom only in 10%

    • claudication

      • tight cramp-like pain in muscles of calf, thigh or buttock

      • reproduced with exercise

      • relieved within 10mins of rest

    • 50% have atypical leg pain

    • remainder are asymptomatic

  • ischaemic rest pain = increase severity

    • increase risk to limb

    • burning pain in arch or distal foot that occurs when feet elevated

  • ddx for claudication

    • venous claudication

    • neurogenic claudication (spinal stenosis)

    • popliteal artery entrapment

    • Raynaud’s phenomenon

    • other vasospastic

Ankle-brachial pressure index

  • non invasive way for detecting or ruling-out presence of Peripheral artery disease

  • calculation:

    • systolic BP at ankle: arm
  • healthy = 1.0-1.4

    • systolic at ankle > arm
  • abnormal low (\<0.9)

    • sens 79-95%

    • spec 95%

    • = peripheral artery disease

  • \<0.4 = critical limb ischaemia

    • severely reduced circulation

    • ischaemic rest pain

    • tissue loss due to ulceration and/or gangrene

  • > 1.4 = inconclusive and refer to vascular lab

  • used to assess safety of compression treatment

    • if >0.8 then hoisery considered safe

    • if \<0.8 but >0.5 - low compression (\<30mmHg = safe)

    • if \<0.5 then no hoisery

  • insufficient evidence for population screening

  • offer @ risk

    • older

    • smoking

    • DM

    • hyperlipidaemia

    • HTN

    • reduced renal function

  • in particular:

    • 50-69 who smoke or DM

    • >70yo

    • Framingham >10%

  • 12% of gen pop have congenital absence of dorsalis pedis

  • limitations

    • doppler measures flow not amount of blood

    • technique not able to determine exact location of arterial stenois/occlusion

    • falsely elevated in patients with calcification of medial arteries

      • dm

      • renal dysfunction

      • rheumatoid arthritis

    • arterial stenosis may present with intermittent claudication and normal ankle pressure @ rest

Referal

urgent:

  • ABPI \<0.5

  • known eripheral artery disease with new ulcer/area of necrotic tissue

  • ulcer that is not responding to Rx

  • intermittent claudication when walking for \<200m

  • young and otherwise healthy pt with caludication

    • rule out rare causes

      • popliteal artery entrapment

discussion:

  • doubt re diagnosis

  • uncertainty around significance of ABPI

  • doubt about need for treatment

Treatment

  • improve QOL

  • reduce overall cardiovascualr risk

  • if ABPI\<0.9

    • peripheral artery disease

    • 5yr cardiovascular risk >20%

    • intensive risk factor management

  • lifestyle

    • smoking

    • walk 20min/day

      • exercise to point of maximal pain

        • improved limb function and general health

          • improved distal blood flow following creation of new collateral blood vessals

          • release of vasodilating compunds

            • nitric oxide
  • pharmacological

    • ACEi may improve walking ability

      • 120m

      • painfree increase by 75m

      • ramipril = greatest effect

      • ?class effect

    • antiplatlet

    • statin

      • 17.6% reduction in cardiovascular events in people with PVD simvastatin and TC> 3.5

      • atherosclerotic plaque stabilisation

      • plaque regression

        • independently of lipidlowering ability
    • HTN taget 130/80

    • HbA1c = ≤50-55

    • renal function

      • microalbuminuria = earliest sign of diabetic kidney disease
  • beta blockers

    • may be used cautiously continued in patients with PAD

    • cochrane review: no evidecne

      • adversely affected walking distance, calf blood flow or vascular resistance in patients with peripheral artery disease